Table 1.
Clinical outcomes across 3-month observation period.
| Outcome Measures | Baseline | Month 1 | Month 2 | Month 3 |
|---|---|---|---|---|
| M(SD) | M(SD) | M(SD) | M(SD) | |
| Number of counseling sessions | 0.73 (0.79) | 1.00 (1.18) | 0.90 (0.99) | 1.60 (1.40) |
| Urinalysis results (% positive, illicit drugs) 1 |
0.0 (0.0) |
0.0 (0.0) |
0.0 (0.0) |
0.0 (0.0) |
| Addiction Severity Index (ASI) composite scores | ||||
| Drug | 0.094 (0.046) | 0.086 (0.02) | 0.085 (0.019) | 0.086 (0.02) |
| Alcohol | 0.004 (0.011) | 0.012 (0.028) | 0.008 (0.021) | 0.002 (0.005) |
| Medical | 0.567 (0.387) | 0.419 (0.378) | 0.297 (0.364) | 0.392 (0.305) |
| Employment | 0.366 (0.169) | 0.372 (0.177) | 0.377 (0.173) | 0.371 (0.173) |
| Legal | 0.000 (0.0) | 0.000 (0.0) | 0.000 (0.0) | 0.000 (0.0) |
| Family/Social | 0.157 (0.185) | 0.170 (0.240) | 0.115 (0.194) | 0.164 (0.223) |
| Psychiatric | 0.185 (0.195) | 0.200 (0.251) | 0.207 (0.218) | 0.188 (0.253) |
1
One participant tested EtG-positive at baseline, another participant tested EtG-positive in month 3.